Doctor profile · Federal record
Dr. ANNA BELCHEVA, M. D.
Medical Oncology Physician (CMS: MEDICAL ONCOLOGY) · Hematology & Oncology Physician · HOUSTON, TX
- NPI 1518928514
- Accepts Medicare
- 28 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
18220 STATE HIGHWAY 249, SUITE 130
HOUSTON, TX 770704347
(281) 737-0435
fax (281) 737-0429
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- November 16, 2017
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Texas #L2798
- Medicaid (5)
- TX #162526104 · TX #162526105 · TX #162526103 · TX #162526106 · TX #162526102
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518928514. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
63,994
Distinct HCPCS
10
Medicare allowed
$783,918
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 23,460 | 29 | $1 | |
J1756 |
Injection, iron sucrose, 1 mg | 9,800 | 21 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 9,400 | 15 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,040 | 15 | $3 | |
J1453 |
Injection, fosaprepitant, 1 mg | 4,950 | 11 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 4,080 | 22 | $22 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,041 | 47 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 579 | 225 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 534 | 200 | $129 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 430 | 14 | $1 |
In context: peer comparison
Among 72 peers in this city , average services per provider: 632. This provider delivers 101× the peer median.Open Payments
Industry payments received
All-time total
$4,017
Transactions
126
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $356.65 | |
| Janssen Biotech, Inc. | 13 | $344.25 | |
| SpringWorks Therapeutics, Inc. | 15 | $267.55 | |
| Novartis Pharmaceuticals Corporation | 13 | $255.14 | |
| Tempus AI, Inc | 12 | $224.11 | |
| PFIZER INC. | 11 | $205.55 | |
| Celgene Corporation | 6 | $156.42 | |
| Daiichi Sankyo Inc. | 6 | $141.72 | |
| Eisai Inc. | 6 | $132.91 | |
| Astellas Pharma US Inc | 7 | $123.73 | |
| SOBI, INC | 4 | $109.82 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106.05 | |
| GENZYME CORPORATION | 4 | $100.13 | |
| JAZZ PHARMACEUTICALS INC. | 4 | $95.21 | |
| Gilead Sciences, Inc. | 4 | $84.14 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
587
Patients
152
Total drug cost
$12,690
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 123 | 38 | $3,335 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 67 | 18 | $2,719 |
| Tramadol Hcl | Generic | 56 | 22 | $300 |
| Tamoxifen Citrate | Generic | 52 | 15 | $1,674 |
| Gabapentin | Generic | 42 | 15 | $385 |
| Ondansetron Odt (Ondansetron) | Brand | 39 | 21 | $435 |
| Dexamethasone | Generic | 34 | 12 | $331 |
| Alprazolam | Generic | 26 | 0 | $360 |
| Levothyroxine Sodium | Generic | 26 | 0 | $240 |
| Celecoxib | Generic | 22 | 0 | $2,160 |